Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
depression
,
major depressive disorder
,
depressive disorder
Glycididazole
carcinoma
,
esophageal neoplasms
,
squamous cell carcinoma
Taxane
melanoma
,
kidney neoplasms
,
colonic neoplasms
,
neoplasms
,
squamous cell carcinoma of head and neck
,
pancreatic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
squamous cell carcinoma
,
esophageal neoplasms
,
colorectal neoplasms
,
head and neck neoplasms
,
squamous cell neoplasms
,
brain neoplasms
,
esophageal squamous cell carcinoma
,
urologic neoplasms
,
uterine cervical neoplasms
,
pancreatic ductal carcinoma
,
small cell carcinoma
,
non-muscle invasive bladder neoplasms
,
mouth neoplasms
,
oropharyngeal neoplasms
,
lip neoplasms
,
laryngeal neoplasms
,
hypersensitivity
,
adenocarcinoma of lung
,
recurrence
,
malignant pleural effusion
,
carcinosarcoma
,
xerostomia
,
mucositis
,
radiation injuries
,
radiation effects
,
gastrointestinal neoplasms
,
sarcoma
,
breast neoplasms
,
lung neoplasms
,
neoplasm metastasis
,
ovarian neoplasms
,
triple negative breast neoplasms
,
stomach neoplasms
,
prostatic neoplasms
,
endometrial neoplasms
,
adenocarcinoma
,
carcinoma
,
small cell lung carcinoma
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
uterine neoplasms
,
biliary tract neoplasms
,
breast diseases
,
endometrioid carcinoma
,
mucinous cystadenocarcinoma
,
acinar cell carcinoma
,
unknown primary neoplasms
,
castration-resistant prostatic neoplasms
,
non-small-cell lung carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use